The unique challenges integrating AI into biotechnology - opinion

The unique challenges integrating AI into biotechnology - opinion
jpost.com

by By JOHANNA STERN • 1 month ago

AI is transforming biotechnology, as evidenced by significant investments like CytoReason's $80 million funding from Nvidia and Pfizer. This integration enhances drug discovery, protein engineering, and diagnostics while raising intellectual property challenges. Issues include determining inventorship, balancing patent disclosure with trade secrets, and ensuring compliance with legal requirements. As AI’s influence grows, strategic planning in patenting and protecting innovations becomes essential for success in this evolving field.

Summarized in 80 words

Latest AI Tools

More Tech Bytes...